Henry Ford Health System
Video: DIAMOND study provides ‘interesting data’ on hyperkalemia reduction
In this video, David E. Lanfear, MD, advanced HF specialist and program director of the Advanced Heart Failure Fellowship at the Henry Ford Health System in Detroit, spoke to Healio about two clinical trials presented at the American College of Cardiology Scientific Session.
Video: Electronic health records could be ‘rapidly adopted’ in HF treatment
In this video, David E. Lanfear, MD, advanced HF specialist and program director of the Advanced Heart Failure Fellowship at the Henry Ford Health System in Detroit, spoke to Healio about a late-breaking trial presented at the American College of Cardiology Scientific Session
Video: New guidelines help relabel heart failure
In this video, David E. Lanfear, MD, MS, FHFSA, advanced HF specialist and program director of the Advanced Heart Failure Fellowship at the Henry Ford Health System in Detroit, discusses the new HF guidelines presented at the American College of Cardiology Scientific Session.
Multimodal non-opioid protocol may reduce pain after arthroscopic rotator cuff repair
Compared with traditional opioid analgesics, a multimodal non-opioid pain protocol provided equivalent or better postoperative pain control for patients who underwent primary arthroscopic rotator cuff repair, according to published results.
Risk stratification, molecular testing among recent advances in thyroid cancer treatment
During the past 2 decades, Endocrine Today has reported on the latest developments in treating thyroid cancer. For its 20th year, the publication is taking a look back.
Gastrointestinal cancer specialist joins Henry Ford Cancer Institute
Philip A. Philip, MD, PhD, has been appointed director of gastrointestinal oncology and neuroendocrine oncology at Henry Ford Cancer Institute.
Multimodal nonopioid pain protocol yielded effective pain control after ACL reconstruction
Opioid use prior to arthroscopic rotator cuff repair may lead to worse outcomes
SAN DIEGO — Opioid use prior to arthroscopic rotator cuff repair may lead to worse outcomes, according to results presented at the American Academy of Orthopaedic Surgeons Annual Meeting.
GALACTIC-HF: Omecamtiv mecarbil effective in Black patients with HF
Omecamtiv mecarbil was safe and effective compared with placebo in Black patients with HF with reduced ejection fraction, according to new data from GALACTIC-HF presented at the Heart Failure Society of America Annual Scientific Meeting.